FDA Investigator Jee Chung, PhD
Jee Chung, PhD has conducted inspections on 5 sites in 1 countries as of 06 Feb 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
06 Feb 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jee Chung, PhD:
Aimee Cunningham, PhD,
Alice S Tsao,
Amalia C Himaya,
Amy Devlin, PhD,
Anastasia G Lolas,
Andrea Siegel, PhD,
Anissa M Cheung,
Anita Narula, PhD,
Anjali Shukla, PhD,
Arie C Menachem,
Ashutosh Rao, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Bonita S Chester,
Brenda P King,
Brentley S Collins,
Brian M Janelsins, PhD,
Brien C Fox,
Brooke K Higgins,
Burnell M Henry,
Carla J Lundi,
Caryn M Mcnab,
Chaltu Nwakijra,
Charles L Zhou,
Charles R Cote, RIC,
Charles Yuanchia Kuo, PhD,
Cheron M Portee,
Christian D Lynch (CDL),
Christina C Santos,
Christina Capacci Daniel, PhD,
Christina V Santos,
Christopher Downey, PhD,
Constance L Richard,
Daniel W Cline,
Davinna Ligons, PhD,
Dawn M Braswell,
Devaughn Edwards,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Donna Ltartaglino Besone,
Dr. Zhihao Qiu (Peter), PhD,
Ekaterina Allen,
Ellen P Madigan,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Gene D Arcy,
Gregory R Brinsley,
Gunther Boekhoudt, PhD,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
Ivan E Reyes,
Jacek Cieslak, PhD,
Jacob W Reynolds,
James R Fleckenstein,
Janis R Armedoriz,
Jason F Chancey,
Jeffrey P Raimondi,
Jeffry A Bernhardt,
Jennifer Gogley,
Jennifer M Gogley,
Jennifer Swisher, PhD,
Joel D Hustedt,
Joel Welch, PhD,
John R Myung,
Jonathan W Chapman,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Justin A Boyd,
Justine M Corson,
Ka L Wong,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kathy Lee,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Laura Fontan, MS,
LCDR Debra Emerson,
Leonard H Lavi,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Lori B Wikstrom,
LT Richard A Lyght,
Madushini Dharmasena, PhD,
Marcia B Williams,
Marcus F Yambot,
Maria Gutierrez Lugo, PhD,
Marie A Fadden,
Martha T Olone,
Mary E Farbman, PhD,
Mary Kaulee,
Maxwell Van Tassell, PhD,
Maxyne T Lam,
Megan A Haggerty,
Michael Shanks, MS,
Michelle A Marsh,
Michelle M Noe Varga,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Monique C Lo,
Nailing Zhang,
Nebil A Oumer,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Ogechi C Nna,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Penny H Mccarver,
Peter S Diak,
Prabhu P Raju,
Priscilla M Pastrana,
Rachel C Harrington,
Rebecca Rodriguez,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Thornton,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Robert J Martin,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sandra A Hughes,
Sarah Arden,
Scott R Nichols, PhD,
Sean R Marcsisin,
Seneca D Toms,
Seth A Mailhot,
Shadia Zaman, PhD,
Sidney B Priesmeyer,
Simon Williams, PhD,
Sonia R Peterson,
Sonya M Edmonds,
Stacey S Degarmo,
Stanley Au,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Tamika White,
Teegan Dellibovi Ragheb, PhD,
Tenzin Jangchup,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thuy T Nguyen, LCDR,
Uttaniti Limchumroon (Tom),
Veronica Fuentes, MS,
Victor J Gangi,
Walter N Lange,
Wayne E Seifert,
Wendy G Tan, PhD,
Xiaoshi N Wang,
Xiaoxiao Pan, PhD,
Xuhong Li,
Yanming An, PhD,
Ying Xin Fan, PhD,
Yuan Chia Kuo,
Yumi J Hiramine,
Yun Wu, PhD,
Yvonne C Wilkes,
Zhenzhen Liu, PhD
Jee Chung, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2019 | EIR | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - EIR, 2019-01-18 |
| May, 2017 | FDA 483 | Amgen, Inc - Form 483, 2017-05-16 |
| April, 2013 | FDA 483 | Human Genome Sciences, Inc. - Form 483, 2013-04-26 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-18 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-17 |
| February, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2023-02-10 |
| January, 2014 | FDA 483 | Kingchem Laboratories Inc. - Form 483, 2014-01-10 |
| July, 2024 | FDA 483 | Lonza Biologics, Inc. - Form 483, 2024-07-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more